Factors associated with medication non-adherence in patients with dyslipidemia

Eman Alefishat, Anan S. Jarab, Walid Al-Qerem, Lina Abu-Zaytoun

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Lack of medication adherence among patients with dyslipidemia negatively affects health-related outcomes. This study aims to evaluate medication adherence; we also aim to investigate the predictors of non-adherence among patients with dyslipidemia in Jordan. Medication adherence was evaluated in a total of 228 dyslipidemia patients. The Beliefs about Medicines Questionnaire was also used to assess patients’ beliefs about medications. The majority of the current study participants (73.2%) reported non-adherence to the prescribed medications. There were significant negative associations between medication adherence and concerns of prescription drug use (B = −0.41, p-value < 0.01), duration of dyslipidemia (B = −0.22, p-value < 0.01), and the number of medications (B = −0.64, p-value < 0.01). Positive associations were found between medication adherence and the necessity of prescription drug use (B = 0.43, p-value < 0.01), taking statin and fibrate (B = 2.04, p-value < 0.01), and moderate-intensity statin (B = 2.34, p-value < 0.01). As for patients’ beliefs about medications, the item “My medicine to lower my cholesterol disrupted my life” had the highest mean (3.50 ± 0.99). This study revealed a low adherence rate to medication among patients with dyslipidemia. It also demonstrates modifiable factors such as beliefs regarding perceived risk, medication harms, treatment duration, and the number of medications associated with poor adherence in patients with dyslipidemia.

Original languageBritish English
Article number813
JournalHealthcare (Switzerland)
Issue number7
StatePublished - Jul 2021


  • Adherence
  • Dyslipidemia
  • Statin


Dive into the research topics of 'Factors associated with medication non-adherence in patients with dyslipidemia'. Together they form a unique fingerprint.

Cite this